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The term tremor used throughout the paper has been more recently replaced by the term twitches which is 







In dogs with metaldehyde intoxication, are benzodiazepines (e.g. diazepam, midazolam) more effective than 
methocarbamol in relaxing muscles and reducing tremors? 
  
Clinical bottom line 
Category of research question 
Treatment 
The number and type of study designs reviewed 
Five papers were critically reviewed. There were five retrospective case series 
Strength of evidence 
Weak 
Outcomes reported 
Currently, five retrospective case series exist in the literature which discuss metaldehyde intoxication cases 
treated mainly with benzodiazepines, a few of which had methocarbamol. There is not really any study to 
compare directly benzodiazepines with methocarbamol. In addition to that, factors such as commercial (e.g. 
the low availability of methocarbamol in the UK market compared to the US market), administrational (e.g. 
multiple administration routes of benzodiazepines) and pharmacological (e.g. lack of anticonvulsant function 
of methocarbamol), have played an important role in the treatment choice. Several case reports exist as well 
Conclusion 
Currently, there is insufficient evidence to determine whether benzodiazepines are more effective than 
methocarbamol in relaxing muscles and reducing occurrence of muscle tremors 
  
How to apply this evidence in practice 
The application of evidence into practice should take into account multiple factors, not limited to: individual 
clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the 
individual case in front of you, the availability of therapies and resources. 
Knowledge Summaries are a resource to help reinforce or inform decision-making. They do not override the 
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Clinical Scenario  
A 4-year-old male neutered dog is presented to you as an emergency due to acute ongoing generalised muscle 
tremors. Prior to the episode, the dog was out for a walk at the neighborhood. Physical examination reveals 
hyperthermia (40.5oC), neurological examination reveals generalised muscle tremors, however the dog is 
bright, alert and responsive. Based on generalised muscle tremors and absence of other neurological findings, 
you suspect that the hyperthermia is secondary to the tremors, and you neurolocalise forebrain, cerebellum, 
meninges (pyrexia), peripheral nerve or multifocal, as it is difficult to clinically establish the origin of 
generalised muscle tremors. You observe some watery discharge of blue/green colour from the anus, 
compatible with the colour of the commercial form of slug bait, and thus you suspect metaldehyde 
intoxication. Would you choose methocarbamol or benzodiazepines to relax the muscles and reduce the 
tremors of the dog? 
 
The evidence 
Five studies of indirect relevance to the PICO were reviewed, all of them being retrospective in nature. Due to 
a lack of prospective or retrospective studies with direct correlation of benzodiazepines and methocarbamol 
treatment without administration of other medications (e.g. antiepileptic drugs), the strength of the evidence 
is extremely low. 
 
Summary of the evidence 
 
1. Firth (1992) 
Population: Dogs with snail bait poisoning (metaldehyde or methiocarb) and 
follow-up. This study was conducted in Australia 
Sample size: 56 dogs 
Intervention details:  26/56 dogs were intoxicated by metaldehyde (30/56 dogs 
were intoxicated by methiocarb) 
 There is no information whether the intoxicated dogs 
manifested epileptic seizures, tremors or both 
 There is no information whether the dogs were amenable or 
not to administration of oral medications upon presentation 
 Treatment was achieved with sedatives, general 
anaesthetics and/or muscle relaxants including:  
a. diazepam premedication (9/26) 
b. diazepam/ketamine general anaesthesia (GA) (12/26) 
c. diazepam/ketamine/lidocaine GA (7/26) 
d. lidocaine/ketamine GA (1/26) 
e. methocarbamol (post-GA) (6/26) 
 Methocarbamol was given only after performing GA with 
either one of the above mentioned GA protocols, but not as 
sole medication 
 Two dogs were lost to follow-up 
Study design: Retrospective, single centre, case series 
Outcome studied:  Different management protocols (including the use of 
premedication, general anaesthesia and post-general 
anaesthesia relaxants) 
 The correlation between the treatment modality and 
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(relevant to PICO question): 
There was full recovery of 100% (24/24) metaldehyde intoxication 
cases using multimodal treatment, most of which included 
diazepam. However, there was no comparison between the usage of 
benzodiazepines and methocarbamol 
Limitations:  This is a retrospective, single centre, case series study with a 
low level of evidence. 
 The usage of methocarbamol was additional to a GA 
protocol that might or might not include diazepam 
 The outcome was not correlated with the specific treatment 




2. Yas-Natan et al. (2007) 
Population: Dogs diagnosed with metaldehyde. This study was conducted in 
Israel (School of Veterinary Medicine, The Hebrew University of 
Jerusalem) 
Sample size: 18 dogs 
Intervention details:  All cases were intoxicated by metaldehyde and presented 
with a variety of clinical signs 
 16/18 dogs presented with epileptic seizures and 10/18 dogs 
presented with muscle tremors amongst other clinical signs 
 Only 2/18 dogs were amenable to administration of oral 
medications upon presentation as they were not presented 
with status epilepticus or altered mentation. Nevertheless, 
only injectable medications were administered within the 
study 
 Monotherapy (6/18 dogs) or multimodal treatment was 
administered (12/18 dogs) including one, or more than one, 
of the medications below: 
a. diazepam (17/18) 
b. phenobarbital (7/18) 
c. pentobarbital (6/18) 
d. isoflurane (9/18) 
 Diazepam was administered in a dose of 0.28–6.3 mg/kg IV 
q24h 
Study design: Retrospective, single centre, case series 
Outcome studied:  Clinical signs and clinicopathological findings  
 Different management protocols 
 The correlation between the treatment modality and 
patients’ response and outcome 
Main findings: 
(relevant to PICO question): 
Dogs with metaldehyde intoxication which were mostly treated with 
multimodal treatment including diazepam had overall a good 
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Limitations:  This is a retrospective, single center, case-series study with a 
low level of evidence. 
 This is a study which does not concentrate on the treatment. 
No information provided for the type of treatment in 
conjunction with the outcome 
 The treatment of the dogs with metaldehyde intoxication is 
multimodal, and the majority of dogs were treated with 
barbiturates. As the barbiturates are successful antiepileptic 




3. Zimmermann et al. (2010) 
Population: Dogs with status epilepticus due to acute intoxications. This study 
was conducted in Germany (Ludwig Maximilian University of 
Munich) 
Sample size: 14 dogs (three of them diagnosed with metaldehyde intoxication) 
Intervention details:  3/3 cases were intoxicated by metaldehyde and presented 
with status epilepticus 
 0/3 presented with muscle tremors 
 None of the dogs (0/3) were amenable to administration of 
oral medications as per status epilepticus upon presentation 
 All metaldehyde intoxicated dogs were administered 
phenobarbital alone or with other medications, whilst two 
of them were treated with diazepam. Specifically: 
a. dog 1: phenobarbital, pentobarbital  
b. dog 2: diazepam, acepromazine, atropine, 
phenobarbital, pentobarbital 
c. dog 3: lidocaine, diazepam, propofol, pentobarbital 
 For dog 2, diazepam was administered initially 0.5–1.0 
mg/kg IM and then IV, whilst for dog 3 only IV 
Study design: Retrospective, single centre, case series 
Outcome studied:  Describe intoxication aetiology for dogs with status 
epilepticus 
 Describe clinical presentation 
 Different management protocols 
 The correlation between the treatment modality and 
patients’ response and outcome 
Main findings: 
(relevant to PICO question): 
 Dogs with metaldehyde intoxication which were treated in 
hospital with phenobarbital (2/3), pentobarbital (3/3), 
diazepam (2/3) and other medications survived 
 All dogs were discharged with oral antiepileptic treatment 
(phenobarbital), which was tapered gradually until 
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 Telephone follow-up was done for all dogs in the study 
(median follow-up time 2.6 years); the three dogs with 
metaldehyde intoxication were alive with no further seizures 
 All metaldehyde intoxicated dogs survived 
Limitations:  This is a retrospective, single centre, case series study with a 
low level of evidence.   
 This study is a general intoxication study, which does not 
concentrate specifically on metaldehyde intoxication. Thus, 
the case number is very low (n=3), where only 2/3 have 
been treated with diazepam 
 The treatment of the dogs with metaldehyde intoxication is 
multimodal, and particularly all dogs are treated with 
pentobarbital or phenobarbital. As phenobarbital and 
pentobarbital are of the barbiturate family, they are very 
successful antiepileptic drugs, the conclusion of diazepam 
efficacy is unreliable 
 The whole study does not provide detailed findings for every 
individual case (follow-up time, outcome, etc.) making the 
strength of evidence even lower 
 
 
4. Jull et al. (2011)  
Population: Dogs with status epilepticus due to acute intoxications. This study 
was conducted in the UK (Royal Veterinary College, Animal Health 
Trust) 
Sample size: 20 dogs (17 cases were intoxicated by metaldehyde and presented 
with status epilepticus) 
Intervention details:  All dogs (17/17) had epileptic seizures (status epilepticus), 
however, it is not stated whether some of these dogs had 
muscle tremors as well 
 None of the dogs (0/17) were amenable to administration of 
oral medications as per status epilepticus upon presentation 
 Metaldehyde intoxicated dogs received monotherapy or 
multimodal therapy. More specifically:  
a. 8/17: diazepam (monotherapy) 
b. 3/17: diazepam + phenobarbital 
c. 1/17: diazepam + propofol  
d. 1/17: midazolam (monotherapy) 
e. 2/17: midazolam + propofol 
f. 2/17: phenobarbital + propofol 
Study design: Retrospective, multi-centre (two centres), case series 
Outcome studied: Whether prolonged status epilepticus, secondary to a 
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(relevant to PICO question): 
 Dogs with metaldehyde intoxication which were treated 
with benzodiazepine monotherapy (diazepam or midazolam) 
survived and did not manifest any post intoxication seizures 
 3/17 dogs of the metaldehyde intoxication group were 
discharged with oral antiepileptic treatment (phenobarbital) 
which was tapered gradually until discontinuation 
 Median follow-up time for the 20 dogs was 757 days. The 17 
dogs with metaldehyde intoxication survived and none of 
them manifested any post intoxication seizures 
 All metaldehyde intoxicated dogs survived 
Limitations:  This is a retrospective, multi-centre, case series study with a 
low level of evidence 
 The multi-center nature of the study increases the possibility 
of non-standardised protocols between the centres, and 
thus the strength of the study 
 There was no case treated with methocarbamol 
 Due to the nature of the study, no direct comparison 
between the different treatments can be reliably assumed 
 
 
5. Bates et al. (2012) 
Population: Dogs with suspected metaldehyde intoxication (slug bait poisoning) 
with follow-up; cases reported to the Veterinary Poisons 
Information Service (VPIS) through phone calls by veterinary 
practices. This study was conducted in the UK (1985–2010) 
Sample size: 772 dogs 
Intervention details:  597/772 dogs were symptomatic 
 Only 528/597 dogs developed increased muscular activity, 
such as tremor, twitching, muscle spasms or fasciculation, 
epileptic seizures or opisthotonos  
 290/597 dogs were presented with convulsions and 136/597 
with tremors, whilst the rest had a variety of other 
neurological or extraneural signs 
 There is no information whether the dogs were amenable or 
not to administration of oral medications upon presentation 
 Treatment, on either symptomatic or asymptomatic 
intoxicated dogs was achieved with one, or more than one, 
of the medications below:  
a. benzodiazepines (392/772) 
b. barbiturates (227/772) 
c. propofol (90/772) 
d. acepromazine (70/772) 
e. isoflurane (4/772) 
f. methocarbamol (2/772) 
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 496/597 dogs required more than one sedative or 
anaesthetic agent 
 18 of the responding veterinarians who used diazepam 
reported that diazepam appeared to be ineffective and an 
alternative sedative was required 
Study design: Retrospective, multi-centre, case series 
Outcome studied:  To analyse retrospectively telephone enquiries of referring 
veterinarians who confront dogs poisoned by metaldehyde  
 Describe clinical features 
 The correlation between the treatment modality and 
patients’ response and outcome 
Main findings: 
(relevant to PICO question): 
 Benzodiazepines remain a major option for metaldehyde 
intoxication treatment for the 50% of the cases, however 
there is evidence that refractory cases require further 
medications/anaesthetics 
 The use of barbiturates and benzodiazepines remained fairly 
constant over the period examined 
 Benzodiazepines were given to half the dogs in this cases 
series 
 Methocarbamol was used only in two cases most likely as a 
result of the decreased availability in the UK 
Limitations:  This is a retrospective, multi-centre, case series study with a 
low level of evidence 
 The multi-centre and questionnaire based nature of the 
study increases the possibility of non-standardised protocols 
between the centres, and thus the strength of the study 
 There were only two cases treated with methocarbamol, 
with no detailed reference as to the outcome 
 The outcome was not correlated with the specific treatment 
that each dog had, making any evaluation of the 





Appraisal, application and reflection 
 
Metaldehyde intoxication is a common intoxication in dogs attributed to ingestion of slug bait, which consists 
of the carbamate named metaldehyde. Clinical signs include generalised muscle tremors and/or epileptic 
seizures, as well as a variety of other signs (Dolder, 2003). Among others (e.g. metabolic acidosis), one of the 
major causes of death in such cases is the hyperthermia secondary to the excessive generalised muscle 
tremors (Dolder, 2003). Consequently, one of the major therapeutic goals of the general practitioner is to 
decrease the muscle tremors, avoiding hyperthermia. As mentioned already, there are no prospective or 
retrospective studies in the literature to compare different treatments for metaldehyde intoxication in dogs 
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Benzodiazepines bind to γ-aminobutyric acid (GABA) receptors of the brain resulting in increased GABA 
activity, which is the main neurotransmitter of the brain. Consequently, they are used as centrally acting 
skeletal muscle relaxants, but also as anxiolytics, sedatives, hypnotics and anticonvulsants (Podell, 1995; and 
Van Tulder et al., 2003). Benzodiazepines are quite beneficial as most of them can be administered through 
different routes (intravenous [IV], intramuscular [IM], per os [PO], intranasal [IN], intrarectal [IR]) (Podell, 
1995; and Charalambous et al., 2017). Diazepam reaches therapeutic plasma levels within 10 minutes when 
administered IN or IV (Musulin et al., 2011) or IR (Papich & Alcorn, 2007) or 30 minutes to 2 hours when 
administered PO (Plumb, 2008). Diazepam IM has a slower and incomplete absorption (Plumb, 2008). The 
serum half-life of diazepam in dogs is 2.5–3.2 hours (Plumb, 2008). Diazepam’s major drawbacks include: (a) 
possible cause of contradictory response (central nervous system excitement) (Plumb, 2008); (b) sedative 
inefficacy (Plumb, 2008); (c) tolerance to its anticonvulsant effect in dogs (Frey et al., 1984); and (d) inability to 
administer as a constant-rate infusion (CRI) solution as its availability might be reduced within the plastic 
syringe (Cloyd et al., 1980). Midazolam’s unique solubility characteristics (water soluble injection but with high 
lipophilicity at body pH) give it a very rapid onset of action after injection (Plumb, 2008). Although midazolam 
IV provides the quickest onset of action (Plumb, 2008), IN route provides superiority when the time needed to 
place an IV catheter is taken into account and same efficacy (Charalambous et al., 2019). Midazolam IM is 
rapidly and completely absorbed, in contrast with diazepam IM. Midazolam PO is not commercially available, 
whilst midazolam IR is not clinically useful due to very low rectal bioavailability. Compared to diazepam, 
midazolam is nearly 3 times as potent, and has a faster onset of action (in humans 30–97 seconds), but a 
shorter duration of effect. Midazolam can also provide sedation if used with opioids, in contrast to diazepam 
(Plumb, 2008). As a take-home medication, recently, midazolam IN revealed to be superior to diazepam IR for 
status epilepticus (Charalambous et al., 2017). Midazolam’s major drawbacks include: (a) dose-dependence on 
plasma protein concentrations (as it is protein binding); (b) shorter serum half-life (within almost an hour) 
compared to diazepam, and therefore necessity for a CRI; and (c) respiratory depression when used with other 
narcotics (e.g. opioids) (Plumb, 2008). 
 
Methocarbamol is a centrally acting muscle relaxant that selectively blocks polysynaptic reflex pathways in the 
spinal cord without any effect on monosynaptic pathways, whilst it has no direct effect on the contractile 
mechanism of the striated muscle, the nerve fibre or the motor end plate (Van Tulder et al., 2003; and Nielsen 
et al., 2005). It has been used in veterinary medicine in traumatic myopathies or intoxications (including 
tetanus) (Nielsen et al., 2005). Oral tablets are the only commercially available form of methocarbamol, 
although it can be prepared in an off-label enema in hospital. Methocarbamol has an onset of action of about 
30 minutes after oral administration. Its peak levels in humans occur approximately 2 hours after dosing, and 
its serum half-life is about 1–2 hours (Plumb, 2008). In the US, methocarbamol IV is available as well, and 
successful management of tremors has been reported with methocarbamol CRI in cats (Draper et al., 2013). 
Methocarbamol’s major drawbacks include: (a) limited routes of administration in combination with 
availability limited to the oral form in Europe; (b) delayed onset of action compared to benzodiazepines IV; and 
(c) central nervous system depressant effects as a carbamate (sedation, salivation, lethargy, weakness, ataxia) 
(Plumb, 2008). 
 
Most of the above mentioned retrospective studies include benzodiazepines and particularly diazepam as one 
of the most common first-line drugs for the treatment of metaldehyde intoxication. Firth (1992) reported 
metaldehyde intoxicated dogs treated with diazepam or methocarbamol. Both canine groups were treated 
with diazepam or methocarbamol as a part of a multimodal treatment which included additionally a general 
anaesthetic. All dogs recovered, but no comparison between the groups can be made for the efficacy of either 
diazepam or methocarbamol. Yas-Natan et al. (2007) described cases of metaldehyde intoxication treated with 
benzodiazepines, most of which were accompanied by barbiturates (phenobarbital or pentobarbital). Due to 
the administration of the above mentioned antiepileptic drugs, no conclusion can be made about the 
diazepam only efficacy to these patients, whilst no case with methocarbamol treatment is described. 
Zimmerman et al. (2010) treated all three metaldehyde intoxication cases with diazepam followed by 
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however due to the multimodal nature of treatment, no conclusion could be made for the diazepam only 
efficacy. Jull et al. (2011) described similar therapeutic protocols. 
 
Bates et al. (2012) described that general practitioners preference to use of benzodiazepines (392/772 cases) 
among other treatment protocols as either monotherapy or multimodal therapy, with barbiturates being used 
frequently (227/772 cases). Only 2/772 cases were reported to have used methocarbamol in the therapeutic 
protocol. 
 
In practice, the vast majority of dogs suspected to be intoxicated by metaldehyde are presented with epileptic 
seizures (e.g. status epilepticus) and/or generalised muscle tremors. At the time of presentation, the general 
practitioner is not able to distinguish the origin of the clinical signs, and given the emergency nature of these 
cases, injectable benzodiazepines (and specifically diazepam) are the first choice. Injectable benzodiazepines 
offer rapid onset of action and have both antiepileptic and muscle relaxant properties. Additionally, both 
generalised muscle tremors and epileptic seizures usually include motor activity of the facial and masticatory 
muscles and thus jaw movements, which makes any oral administration unsafe for the veterinary surgeon. 
Therefore, these reasons, as well as the restricted administration routes of methocarbamol, could probably 




In conclusion, there is not enough evidence to define whether benzodiazepines (e.g. diazepam, midazolam) or 
methocarbamol is better for the control of muscle tremors during metaldehyde intoxication, thus the answer 
of the current PICO remains open. Although it is reported that the availability of methocarbamol is limited in 
the UK (Bates et al., 2012) and there are no prospective studies describing its efficacy on tremors, it is 
suggested that methocarbamol is very successful in reducing muscle tremors during this intoxication (Dolder, 
2003). Due to possible manifestation of epileptic seizures concurrently with the generalised muscle tremors 
and in the light of their anticonvulsant activity, their broader availability, their multiple administration routes 
and their rapid action when given IV, benzodiazepines are preferred for the initiation of the treatment in cases 
of metaldehyde intoxication by many vets; and they carry on with an antiepileptic drug (e.g. phenobarbital) or 
general anaesthesia (Firth, 1992; Yas-Natan et al., 2007; Zimmermann et al., 2010; Jull et al., 2011; and Bates 
et al., 2012). It is important to note that in the decision-making process, apart from the pharmacological 
features of each medication, all points of care should be taken into consideration such as: (a) best practice: 
each patient should be treated with the best practice that would be to treat the dog immediately with the 
faster acting drug; (b) the patient stress factor: that is no oral medications should be administered in a patient 
with risk of regurgitation or distress; and (c) safety of the staff: that is risks that could arise from 
administration of oral medications in a dog with generalised muscle tremors (including the jaw). Further 
studies are necessary to provide information on the efficacy of benzodiazepines or methocarbamol in patients 
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Databases searched and dates 
covered: 
CAB Abstracts, 1973 to 2019 week 25 
PubMed, 1966 to current 
Search terms: CAB Abstracts: 
1. (dog OR dogs OR canine OR canines OR canis OR bitch OR 
bitches OR puppy OR puppies OR pup OR pups) OR exp 
dogs/ OR exp bitches/ OR exp puppies/ OR exp canidae/ OR 
exp canis/ 
2. metaldehyde.mp. OR exp metaldehyde/ OR 'slug bait'.mp. 
OR tremorgenic  
3. (intoxication OR toxic* OR poison* OR toxicosis) OR exp 
toxicity/ OR exp poisoning/ 
4. 1 AND 2 AND 3 
  
PubMed: 
1. dog OR dogs OR canine OR canines OR canis OR bitch OR 
bitches OR  puppy OR puppies OR pup OR pups 
2. metaldehyde OR slug bait OR tremorgenic 
3. intoxication OR toxic* OR poison* OR toxicosis 
4. 1 AND 2 AND 3 
Dates searches performed: 2 July 2019 
 
 
Exclusion / Inclusion Criteria 
Exclusion: Articles not available in English, articles which were not relevant to 
the PICO question. book chapters, literature reviews, single case 
reports, conference proceedings 
Inclusion: Original peer-reviewed articles in English language with more than 
one dog intoxicated by metaldehyde and treated with 
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CAB Abs 113 16 71 2 11 5 3 5 
PubMed 52 0 36 0 10 1 0 5 
Total relevant papers when duplicates removed 5 
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